Depression
Three studies on vagus nerve stimulation therapy for depression announced
Published in Medical Letter on the CDC and FDA, June 21st, 2006
The studies, taking place at Duke University Medical Center, Emory University and University of Texas Health Science Center, are designed to identify areas of the brain activated by acute and long-term VNS therapy and further establish the rationale for the long-term sustained responses that have been reported with VNS therapy in TRD.
The VNS Therapy Mechanism of Action Advisory Board, chaired by Charles B. Nemeroff, MD,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Carcinogenesis
Bromate mutagenicity is due to oxidative damage causing chromosomal breakage - Child Abuse
Effects of abuse and related adverse experiences in childhood are long lasting - Genetics & Genomics
Gene expression correlates of unexplained fatigue are reported - HIV/AIDS Therapy
Strong HIV prevention programs provide lessons for effective interventions - Polio Vaccine
Reversions in 5'-untranslated region of poliovirus after vaccination are analyzed - Abdominal Aortic Aneurysms
Endologix receives U.S. Food and Drug Administration approval for Visiflex Delivery System - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
